|Bid||4.4000 x 2200|
|Ask||4.4200 x 1200|
|Day's Range||4.3200 - 4.6700|
|52 Week Range||4.3200 - 13.5000|
|Beta (5Y Monthly)||0.55|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 25, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
Concert will present a corporate overview at the H.C. Wainwright and Oppenheimer virtual conferences in March.
Ladies and gentlemen, thank you for standing by, and welcome to the Concert Pharmaceuticals Fourth Quarter 2020 Investor Update Call. Good morning, and welcome to Concert Pharmaceuticals' fourth quarter 2020 investor update.
Concert reports financial results for the year ended December 31, 2020.